3-[5-[3-(1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;bis((E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-en-1-ol);5-bromo-4-methylpyridine-3-carbaldehyde;3,5-dibromo-4-methylpyridine;3-ethoxy-3-oxopropanoic acid;ethyl (E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-enoate;bis(ethyl (E)-3-(5-bromo-4-methyl-3-pyridinyl)prop-2-enoate)

C207H235BBr5N33O22Si5 — CID 159568490

About 3-[5-[3-(1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;bis((E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-en-1-ol);5-bromo-4-methylpyridine-3-carbaldehyde;3,5-dibromo-4-methylpyridine;3-ethoxy-3-oxopropanoic acid;ethyl (E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-enoate;bis(ethyl (E)-3-(5-bromo-4-methyl-3-pyridinyl)prop-2-enoate)

3-[5-[3-(1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;bis((E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-en-1-ol);5-bromo-4-methylpyridine-3-carbaldehyde;3,5-dibromo-4-methylpyridine;3-ethoxy-3-oxopropanoic acid;ethyl (E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-enoate;bis(ethyl (E)-3-(5-bromo-4-methyl-3-pyridinyl)prop-2-enoate) (PubChem CID 159568490) has the molecular formula C207H235BBr5N33O22Si5 and a molecular weight of 4088.13 g/mol. Its IUPAC name is 3-[5-[3-(1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;bis((E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-en-1-ol);5-bromo-4-methylpyridine-3-carbaldehyde;3,5-dibromo-4-methylpyridine;3-ethoxy-3-oxopropanoic acid;ethyl (E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-enoate;bis(ethyl (E)-3-(5-bromo-4-methyl-3-pyridinyl)prop-2-enoate).

Molecular Properties

• Compound Name: 3-[5-[3-(1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;bis((E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-en-1-ol);5-bromo-4-methylpyridine-3-carbaldehyde;3,5-dibromo-4-methylpyridine;3-ethoxy-3-oxopropanoic acid;ethyl (E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-enoate;bis(ethyl (E)-3-(5-bromo-4-methyl-3-pyridinyl)prop-2-enoate)
• PubChem CID: 159568490
• Molecular Formula: C207H235BBr5N33O22Si5
• Molecular Weight: 4088.13 g/mol
• Exact Mass: 4080.31
• IUPAC Name: 3-[5-[3-(1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;bis((E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-en-1-ol);5-bromo-4-methylpyridine-3-carbaldehyde;3,5-dibromo-4-methylpyridine;3-ethoxy-3-oxopropanoic acid;ethyl (E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-enoate;bis(ethyl (E)-3-(5-bromo-4-methyl-3-pyridinyl)prop-2-enoate)
• SMILES: CC1(C)OB(c2ccc3c(c2)c(-c2nc4ccccc4[nH]2)nn3COCC[Si](C)(C)C)OC1(C)C.CCOC(=O)/C=C/c1cncc(-c2ccc3c(c2)c(-c2nc4ccccc4[nH]2)nn3COCC[Si](C)(C)C)c1C.CCOC(=O)/C=C/c1cncc(Br)c1C.CCOC(=O)/C=C/c1cncc(Br)c1C.CCOC(=O)CC(=O)O.Cc1c(/C=C/CO)cncc1-c1ccc2c(c1)c(-c1nc3ccccc3[nH]1)nn2COCC[Si](C)(C)C.Cc1c(/C=C/CO)cncc1-c1ccc2c(c1)c(-c1nc3ccccc3[nH]1)nn2COCC[Si](C)(C)C.Cc1c(Br)cncc1Br.Cc1c(Br)cncc1C=O.Cc1c(CCCO)cncc1-c1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1.Cc1c(CCCO)cncc1-c1ccc2c(c1)c(-c1nc3ccccc3[nH]1)nn2COCC[Si](C)(C)C
• InChI: InChI=1S/C31H35N5O3Si.C29H35N5O2Si.2C29H33N5O2Si.C26H35BN4O3Si.C23H21N5O.2C11H12BrNO2.C7H6BrNO.C6H5Br2N.C5H8O4/c1-6-39-29(37)14-12-23-18-32-19-25(21(23)2)22-11-13-28-24(17-22)30(31-33-26-9-7-8-10-27(26)34-31)35-36(28)20-38-15-16-40(3,4)5;3*1-20-22(8-7-13-35)17-30-18-24(20)21-11-12-27-23(16-21)28(29-31-25-9-5-6-10-26(25)32-29)33-34(27)19-36-14-15-37(2,3)4;1-25(2)26(3,4)34-27(33-25)18-12-13-22-19(16-18)23(24-28-20-10-8-9-11-21(20)29-24)30-31(22)17-32-14-15-35(5,6)7;1-14-16(5-4-10-29)12-24-13-18(14)15-8-9-19-17(11-15)22(28-27-19)23-25-20-6-2-3-7-21(20)26-23;2*1-3-15-11(14)5-4-9-6-13-7-10(12)8(9)2;1-5-6(4-10)2-9-3-7(5)8;1-4-5(7)2-9-3-6(4)8;1-2-9-5(8)3-4(6)7/h7-14,17-19H,6,15-16,20H2,1-5H3,(H,33,34);5-6,9-12,16-18,35H,7-8,13-15,19H2,1-4H3,(H,31,32);2*5-12,16-18,35H,13-15,19H2,1-4H3,(H,31,32);8-13,16H,14-15,17H2,1-7H3,(H,28,29);2-3,6-9,11-13,29H,4-5,10H2,1H3,(H,25,26)(H,27,28);2*4-7H,3H2,1-2H3;2-4H,1H3;2-3H,1H3;2-3H2,1H3,(H,6,7)/b14-12+;;2*8-7+;;;2*5-4+
• InChIKey: MHMXHHKFSFLRAJ-GDQVRNOBSA-N
• XLogP: 45.52
• TPSA: 710.97 Ų
• H-Bond Donors: 12
• H-Bond Acceptors: 47
• Rotatable Bonds: 60
• Heavy Atoms: 273
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	4088.13
LogP ≤ 5	45.52
H-Bond Donors ≤ 5	12
H-Bond Acceptors ≤ 10	47

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 3-[5-[3-(1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;bis((E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-en-1-ol);5-bromo-4-methylpyridine-3-carbaldehyde;3,5-dibromo-4-methylpyridine;3-ethoxy-3-oxopropanoic acid;ethyl (E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-enoate;bis(ethyl (E)-3-(5-bromo-4-methyl-3-pyridinyl)prop-2-enoate)?

The IUPAC name of 3-[5-[3-(1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;bis((E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-en-1-ol);5-bromo-4-methylpyridine-3-carbaldehyde;3,5-dibromo-4-methylpyridine;3-ethoxy-3-oxopropanoic acid;ethyl (E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-enoate;bis(ethyl (E)-3-(5-bromo-4-methyl-3-pyridinyl)prop-2-enoate) (CID 159568490) is 3-[5-[3-(1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;bis((E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-en-1-ol);5-bromo-4-methylpyridine-3-carbaldehyde;3,5-dibromo-4-methylpyridine;3-ethoxy-3-oxopropanoic acid;ethyl (E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-enoate;bis(ethyl (E)-3-(5-bromo-4-methyl-3-pyridinyl)prop-2-enoate).

What is the SMILES notation for 3-[5-[3-(1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;bis((E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-en-1-ol);5-bromo-4-methylpyridine-3-carbaldehyde;3,5-dibromo-4-methylpyridine;3-ethoxy-3-oxopropanoic acid;ethyl (E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-enoate;bis(ethyl (E)-3-(5-bromo-4-methyl-3-pyridinyl)prop-2-enoate)?

The canonical SMILES for 3-[5-[3-(1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;bis((E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-en-1-ol);5-bromo-4-methylpyridine-3-carbaldehyde;3,5-dibromo-4-methylpyridine;3-ethoxy-3-oxopropanoic acid;ethyl (E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-enoate;bis(ethyl (E)-3-(5-bromo-4-methyl-3-pyridinyl)prop-2-enoate) is CC1(C)OB(c2ccc3c(c2)c(-c2nc4ccccc4[nH]2)nn3COCC[Si](C)(C)C)OC1(C)C.CCOC(=O)/C=C/c1cncc(-c2ccc3c(c2)c(-c2nc4ccccc4[nH]2)nn3COCC[Si](C)(C)C)c1C.CCOC(=O)/C=C/c1cncc(Br)c1C.CCOC(=O)/C=C/c1cncc(Br)c1C.CCOC(=O)CC(=O)O.Cc1c(/C=C/CO)cncc1-c1ccc2c(c1)c(-c1nc3ccccc3[nH]1)nn2COCC[Si](C)(C)C.Cc1c(/C=C/CO)cncc1-c1ccc2c(c1)c(-c1nc3ccccc3[nH]1)nn2COCC[Si](C)(C)C.Cc1c(Br)cncc1Br.Cc1c(Br)cncc1C=O.Cc1c(CCCO)cncc1-c1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1.Cc1c(CCCO)cncc1-c1ccc2c(c1)c(-c1nc3ccccc3[nH]1)nn2COCC[Si](C)(C)C.

What is the InChIKey of 3-[5-[3-(1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;bis((E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-en-1-ol);5-bromo-4-methylpyridine-3-carbaldehyde;3,5-dibromo-4-methylpyridine;3-ethoxy-3-oxopropanoic acid;ethyl (E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-enoate;bis(ethyl (E)-3-(5-bromo-4-methyl-3-pyridinyl)prop-2-enoate)?

The InChIKey is MHMXHHKFSFLRAJ-GDQVRNOBSA-N. The full InChI is InChI=1S/C31H35N5O3Si.C29H35N5O2Si.2C29H33N5O2Si.C26H35BN4O3Si.C23H21N5O.2C11H12BrNO2.C7H6BrNO.C6H5Br2N.C5H8O4/c1-6-39-29(37)14-12-23-18-32-19-25(21(23)2)22-11-13-28-24(17-22)30(31-33-26-9-7-8-10-27(26)34-31)35-36(28)20-38-15-16-40(3,4)5;3*1-20-22(8-7-13-35)17-30-18-24(20)21-11-12-27-23(16-21)28(29-31-25-9-5-6-10-26(25)32-29)33-34(27)19-36-14-15-37(2,3)4;1-25(2)26(3,4)34-27(33-25)18-12-13-22-19(16-18)23(24-28-20-10-8-9-11-21(20)29-24)30-31(22)17-32-14-15-35(5,6)7;1-14-16(5-4-10-29)12-24-13-18(14)15-8-9-19-17(11-15)22(28-27-19)23-25-20-6-2-3-7-21(20)26-23;2*1-3-15-11(14)5-4-9-6-13-7-10(12)8(9)2;1-5-6(4-10)2-9-3-7(5)8;1-4-5(7)2-9-3-6(4)8;1-2-9-5(8)3-4(6)7/h7-14,17-19H,6,15-16,20H2,1-5H3,(H,33,34);5-6,9-12,16-18,35H,7-8,13-15,19H2,1-4H3,(H,31,32);2*5-12,16-18,35H,13-15,19H2,1-4H3,(H,31,32);8-13,16H,14-15,17H2,1-7H3,(H,28,29);2-3,6-9,11-13,29H,4-5,10H2,1H3,(H,25,26)(H,27,28);2*4-7H,3H2,1-2H3;2-4H,1H3;2-3H,1H3;2-3H2,1H3,(H,6,7)/b14-12+;;2*8-7+;;;2*5-4+;;;.

What are the key properties of 3-[5-[3-(1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;bis((E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-en-1-ol);5-bromo-4-methylpyridine-3-carbaldehyde;3,5-dibromo-4-methylpyridine;3-ethoxy-3-oxopropanoic acid;ethyl (E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-enoate;bis(ethyl (E)-3-(5-bromo-4-methyl-3-pyridinyl)prop-2-enoate)?

3-[5-[3-(1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;bis((E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-en-1-ol);5-bromo-4-methylpyridine-3-carbaldehyde;3,5-dibromo-4-methylpyridine;3-ethoxy-3-oxopropanoic acid;ethyl (E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-enoate;bis(ethyl (E)-3-(5-bromo-4-methyl-3-pyridinyl)prop-2-enoate) has a molecular weight of 4088.13 g/mol, XLogP of 45.52, 60 rotatable bonds, 12 hydrogen bond donors, and 47 hydrogen bond acceptors.

Where does this data come from?

All data for 3-[5-[3-(1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]propan-1-ol;bis((E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-en-1-ol);5-bromo-4-methylpyridine-3-carbaldehyde;3,5-dibromo-4-methylpyridine;3-ethoxy-3-oxopropanoic acid;ethyl (E)-3-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methyl-3-pyridinyl]prop-2-enoate;bis(ethyl (E)-3-(5-bromo-4-methyl-3-pyridinyl)prop-2-enoate) is sourced from PubChem (CID 159568490), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).